Novavax, Inc. (NVAX) is around the top of the Biotechnology industry according to InvestorsObserver. NVAX received an overall rating of 58, which means that it scores higher than 58 percent of all stocks. Novavax, Inc. also achieved a score of 78 in the Biotechnology industry, putting it above 78 percent of Biotechnology stocks. Biotechnology is ranked 69 out of the 148 industries.
NVAX has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on NVAX!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 58 means the stock is more attractive than 58 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Novavax, Inc. Stock Today?
Novavax, Inc. (NVAX) stock is trading at $50.12 as of 2:36 PM on Wednesday, May 18, a decline of -$1.83, or -3.52% from the previous closing price of $51.95. The stock has traded between $49.60 and $53.25 so far today. Volume today is below average. So far 2,005,498 shares have traded compared to average volume of 5,415,510 shares.
Click Here to get the full Stock Report for Novavax, Inc. stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
